RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact of preserved small nerve fiber function.

Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact of preserved small nerve fiber function.

Add to Collection
2022 Jun 1 RCTs Fist_Author_Year_PM

Full Author : ['Jain, Sunil M', 'Balamurugan, Ramanathan', 'Tandon, Monika', 'Mozaffarian, Neelufar', 'Gudi, Girish', 'Salhi, Yacine', 'Holland, Robert', 'Freeman, Roy', 'Baron, Ralf']
Journal Title : Pain
Chapter : Section3
Journal Year : 2022
Cited by : Not Available

Patients with chronic pain syndromes, such as those with painful peripheral neuropathy due to diabetes mellitus, have limited treatment options and suffer ongoing attrition of their quality of life. Safer and more effective treatment options are needed. O.....

Keywords : ["preserve small nerve fiber function", "painful diabetic peripheral neuropathy impact", "transient receptor potential ankyrin", "randomize doubleblind placebocontrolle trial", "oral inhibitor", "patient", "isc"]